JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.
The use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are seeking when it comes to joint pain, according to new findings to be presented at RSNA 2022.
The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.